Biohaven Ltd. (BHVN)
NYSE
11.88
-0.20 (-1.66%)
Closed
Oct 7, 2026
Day's Range
11.8512.23
52 wk Range
7.4818.57
Financial Statements - BHVN - Biohaven Ltd.
Revenue
0
Net Income
-738.82M▲ 12.7%
EBITDA
-735.45M▲ 16.2%
Free Cash Flow
-610.15M▼ 4.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -745.37M | -885.11M | -436.05M | -567.93M | -218.90M | -114.50M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 7.99M | 39.42M | 26.50M | -1.90M | 6.47M | -4.16M |
| Pre Tax Income | -737.38M | -845.68M | -409.55M | -569.84M | -212.43M | -118.66M |
| Income Tax | 1.44M | 735K | -1.38M | 438K | 1.36M | 0 |
| Net Income | -738.82M | -846.42M | -408.16M | -570.27M | -213.79M | -118.66M |
| EPS Basic | -6.86 | -9.28 | -5.73 | -12.75 | -5.968203 | -3.312666 |
| EPS Diluted | -6.86 | -9.28 | -5.73 | -12.75 | -5.968203 | -3.312666 |
| Basic Shares Outstanding | 107.62M | 91.23M | 71.20M | 44.74M | 35.82M | 35.82M |
| Diluted Shares Outstanding | 107.62M | 91.23M | 71.20M | 44.74M | 35.82M | 35.82M |
| Ebit | -745.37M | -885.11M | -436.05M | -567.93M | -218.90M | -114.50M |
| Ebitda | -735.45M | -877.25M | -429.13M | -566.54M | -217.50M | -114.43M |
| Net Income Continuous Operations | -738.82M | -846.42M | -408.16M | -570.27M | -213.79M | -118.66M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
